WESTFORD, Mass., May 7, 2013 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced that its senior management will present at the UBS Global Healthcare Conference at 10:30 a.m. (ET) on Tuesday, May 21 in New York City.
The presentation by Cynosure President and CEO Michael Davin and Executive Vice President, Treasurer and CFO Timothy Baker will be available via live and archived audio webcast accessible through a link on the Investor Relations section of the Company's website, www.cynosure.com.
About Cynosure, Inc. Cynosure develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, remove multi-colored tattoos, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite and treat onychomycosis. Cynosure's products include a broad range of laser and other light-based energy sources, including Alexandrite, pulse dye, Q-switched, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, visit Cynosure's website at www.cynosure.com.
Scott Solomon Vice President Sharon Merrill Associates, Inc. 617.542.5300 email@example.com
SOURCE Cynosure, Inc.